Teachers apprehensive about returning to school amid the coronavirus pandemic are exploring their end-of-life options to protect their loved ones as COVID-19 infections and deaths continue to climb across the U.S.
Early in the pandemic, two local nurse practitioners couldn’t believe how often they heard anxious talk about finding medical care, both from people with primary care doctors and people who’d been coasting along for years without.
For high school bands in the Mid-South, the pandemic has had them marching to a different beat this summer and, in some cases, not at all because of safety concerns for students. “Just to be honest, we haven’t found a lot of ways to mitigate those risks,” said Dr. Nicholas Hysmith, Le Bonheur’s medical director… Read More
Neil Hayes, MD, MS, MPH, division chief of Hematology and Oncology at the University of Tennessee Health Science Center, is among recipients of the 2020 Team Science Awards from the American Association for Cancer Research (AACR) for his contributions to developing The Cancer Genome Atlas (TCGA), a groundbreaking multisite project to understand cancer at its… Read More
“We are nonstop hands on and we at the end of the day, we’re making a better smile,” said Heath Phillips, a fourth-year University of Tennessee dental student. Phillips and other students are serving dental patients at Healing Hands Health Center. The clinic provides care to individuals without insurance.
It is increasingly clear that the United States will not follow the lead of other countries and bring the deadly COVID-19 pandemic under control. Any return to normalcy will therefore require a vaccine and development of herd immunity. Several vaccine candidates are showing early promise, prompting the big question — when will we have a… Read More
A collaboration between local universities has selected pandemic-related research projects to fund. In July, the University of Memphis (U of M) and the University of Tennessee Health Science Center (UTHSC) announced a joint effort to facilitate SARS-CoV-2 and COVID-19 research projects. August 5: EurekAlert! August 6: The Medical News
Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company with a focus on developing novel medicines for the management of prostate cancer, today announced that it has confirmed in an in vitro study that VERU-111 has anti-inflammatory action against the key cytokines involved in the cytokine storm triggered by the SARS-CoV-2 infection. August… Read More
